Biotechnology - Health Medical Pharma

Filter

Current filters:

Health Medical Pharma

Popular Filters

Vertex licenses novel influenza treatment VX-787 to Janssen

Vertex licenses novel influenza treatment VX-787 to Janssen

18-06-2014

US biotech firm Vertex Pharmaceuticals has inked a deal with health care giant Johnson & Johnson subsidiary…

Anti-viralsBiotechnologyGlobalHealth Medical PharmaJanssenJohnson & JohnsonLicensingVertex PharmaceuticalsVX-787

Executive Q&A: Paul Higham, CEO of immatics

Executive Q&A: Paul Higham, CEO of immatics

27-05-2014

In an interview with The Pharma Letter, immatics chief executive Paul Higham discusses the company's…

BiotechnologyCancerGermanyHealth Medical Pharmaimmatics biotechnologiesImmunologyInterviewsMedicineOncologyVaccination

Boehringer Ingelheim launches diabetes collaboration with Connexios Life Sciences

Boehringer Ingelheim launches diabetes collaboration with Connexios Life Sciences

06-05-2014

German family-owned drug major Boehringer Ingelheim has announced a global research collaboration with…

BiotechnologyBoehringer IngelheimDiabetesGermanyHealth Medical PharmaHealth Medical PharmaIndiaIngelheim am RheinLicensingMajorResearch

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

AAN 2014: Biogen Idec releases new trial data for peginterferon in MS

02-05-2014

US biotech firm Biogen Idec has released new two-year data from the Phase III ADVANCE clinical trial…

Biogen IdecBiotechnologyCytokinesHealth Medical PharmaHealth Medical PharmaImmune systemImmunologyNeurologicalpeginterferon beta-1aResearchUSA

Ambrx and Zhejiang Hisun sign deal over cancer treatment

Ambrx and Zhejiang Hisun sign deal over cancer treatment

30-04-2014

USA-based clinical-stage biopharmaceutical company Ambrx and Chinese pharma firm Zhejiang Hisun Pharmaceutical…

AmbrxBiopharmaceuticalBiotechnologyBusiness FinanceChinaHealth Medical PharmaHealth Medical PharmaLicensingOncologyPharmaceutical industryUSA

Back to top